Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Dec 11;16:6023–6038. doi: 10.2147/JIR.S440722

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 Huang et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

ROC curve analysis of the PLR, APPLE score and APPLE score plus PLR to predict recurrence in patients with nonparoxysmal atrial fibrillation. The PLR was stratified by the tertiles of the PLR (T1, PLR ≤ 75.6; T2, 75.6 < PLR ≤ 114.9; T3, PLR> 114.9). The LAD groups were stratified by the optimal cut-off value (LAD≥42 mm). The area under the curve (AUC) of the LAD, the PLR and the addition of the PLR to the LAD for predicting recurrence was 0.645 (95% CI, 0.601 to 0.690; P < 0.001), 0.596 (95% CI, 0.557 to 0.634; P < 0.001) and 0.675 (95% CI, 0.629 to 0.722), respectively. LAD vs LAD + PLR, P<0.001. The circle on the curve indicates the point corresponding to the optimal value.

Abbreviations: ROC, receiver operating characteristic; PLR, platelet to lymphocyte ratio.